On October 31, 2024 BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, reported its participation in the Advancing Precision Medicine (APM) Annual Conference 2024, taking place November 1-2, 2024, at the Pennsylvania Convention Center in Philadelphia (Press release, BostonGene, OCT 31, 2024, View Source [SID1234647622]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The APM Annual Conference brings together healthcare leaders—including geneticists, oncologists and bioinformaticians—for collaboration and networking in precision medicine. It serves as a vital platform for advancing personalized healthcare and innovative technologies.
Joe Lennerz, MD, PhD, Chief Scientific Officer at BostonGene, will participate in a panel discussion titled "Diagnosis to Treatment – A Case Study in Non-Small Cell Lung Cancer." The session, scheduled for November 1, from 9:00 AM to 10:20 AM, will outline a novel framework for expanding the impact of precision medicine in cancer care. The discussion will emphasize the adoption of NCCN guidelines and strategies to enhance accessibility beyond major cancer centers. It will also focus on leveraging network-based approaches to ensure that world-class diagnostics reach underserved and rural areas, ultimately aiming to reduce disparities in cancer outcomes.
"At APM 2024, we’re excited to explore practical solutions for expanding precision medicine’s reach in cancer care," said Dr. Lennerz. "This session will highlight how network-based approaches can improve diagnostic access in underserved areas, reducing treatment disparities and advancing precision medicine for all patients."
Visit the APM 2024 website for more information.